Abbott Laboratories
Abbott Laboratories (ABT) Option Chain
As of September 25, 2026, Abbott Laboratories is trading at $101.29, a +0.22% change from the previous close. The nearest expiration is Oct 2, 2026. Implied volatility is 34.6%. IV Rank is 90%.
Read more
Tracking the ABT option chain helps you see every strike and expiry on Abbott Laboratories in one view, so you can quickly identify the contracts that fit your thesis and your risk. Abbott Laboratories's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of ABT options activity at a glance. Use our scanner to monitor the ABT option chain in real time and filter for the ABT options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For ABT stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the ABT option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where ABT stock options are being actively traded and where they are not.
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.
The Diagnostic Products segment offers laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and measure infectious agents; point of care systems; cartridges for testing blood; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for use in laboratories. The Nutritional Products segment provides pediatric and adult nutritional products. The Medical Devices segment offers rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; and diabetes care products, as well as neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Abbott Laboratories's full chain across every expiry, highlights the most liquid strikes, and lets you screen ABT options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of ABT stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryMedical Devices
- SectorHealthcare
- IV percentile95.24% Elevated
- Market cap (M$)175,271
- 52 weeks high-25.22%
- 52 weeks low23.57%
- Analyst recommendationBuy
1.60 - Target price$120.75
19.21% above the current stock price - Dividend—
- Payout ratio64.54%
- Earnings date2026-10-21
- P/E32.74
- Future P/E16.70
- EPS (ttm)3.09
- EPS growth next 5 years9.30%
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 31.58 | 2 | 0 | 0.61 | 2.29 | 2.50 | 3.30 | 99.00 | -2.26 | 0.40 | 0.55 | 0.00 | 0.48 | 20 | 68 | 68.42 |
| 39.54 | 17 | 5 | 0.88 | 1.29 | 1.95 | 2.40 | 100.00 | -1.27 | 0.65 | 0.80 | 0.00 | 0.73 | 253 | 104 | 60.46 |
| 47.87 | 6 | 186 | 1.31 | 0.29 | 1.45 | 1.75 | 101.00 | -0.29 | 1.05 | 1.25 | 0.00 | 1.15 | 243 | 131 | 52.13 |
| 56.21 | 70 | 17 | 1.05 | 0.00 | 0.90 | 1.20 | 102.00 | +0.70 | 1.35 | 1.75 | 0.71 | 0.84 | 685 | 143 | 43.79 |
| 64.21 | 68 | 20 | 0.70 | 0.00 | 0.60 | 0.80 | 103.00 | +1.69 | 2.10 | 2.75 | 1.71 | 0.72 | 426 | 177 | 35.79 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full ABT option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→